相关实验视频

Updated: Mar 14, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

手术救助的时间和复杂的跨导管大动脉置换中的死亡率

Tobias Zeus¹, Ayse S Ceylan¹, Kathrin Klein¹

¹Department of Cardiology, Pulmonology, and Vascular Medicine, University Hospital Düsseldorf, Düsseldorf, Germany.

Clinical research in cardiology : official journal of the German Cardiac Society

|March 12, 2026

概括

在跨导管大动脉置换 (TAVR) 期间,紧急的外科救助很少见. 在混合手术室 (HOR) 进行TAVR救助,与传统导管实验室相比,可显著降低死亡率,改善患者的治疗结果.

科学领域:

心脏病学心脏病学
心脏外科手术心脏外科手术
干预心脏病学干预心脏病学

背景情况:

在跨导管大动脉置换 (TAVR) 期间进行手术救助是一个关键但不常见的并发症.
评估影响外科手术救助结果的因素对于改善患者护理至关重要.

研究的目的:

评估医院基础设施,程序设置,时间和血液动力学稳定性对TAVR后需要紧急外科救助的患者的结果的影响.
为了比较TAVR救助在常规导管实验室 (CCL) 和混合手术室 (HOR) 之间的结果.

主要方法:

2009年至2024年间对3039个TAVR手术的单中心分析,重点关注需要紧急外科救助的16名患者.
两个时代的比较:时代1 (2009-2016) 在CCL中转移到OR,和时代2 (2017-2024) 在专门建造的HOR中.
主要终点:住院死亡率. 二级终点:时间到体外生命支持 (ECLS) 和手术切口.

主要成果:

在TAVR病例中的0.53%发生了外科救助.
在CCL组的住院死亡率为100%,而HOR组的死亡率为33.3% (P < 0.01).
在HOR组中,手术干预的时间显著缩短,所有患者都接受了最终治疗,与CCL组不同的是,60%的患者在手术前死亡.

结论:

虽然很少见,但TAVR期间的手术救助与高死亡率有关.
在混合手术室 (HOR) 中执行TAVR救助与手术干预延迟减少和生存率提高有关.
转换时的血液动力学稳定性是TAVR救助期间生存的关键因素.

关键词:

混合动力手术室混合动力手术室基础设施基础设施死亡率死亡率死亡率手术性救助计划可以帮助你.干预的时间到干预的时间透过导管的大动脉替换 (TAVR)

更多相关视频

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

相关概念视频

Aneurysm IV: Nursing Management

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...